Melatonin dosage safety
Pro Research Analysisby 
Searched over 200M research papers
Melatonin Dosage Safety: General Findings
Research consistently shows that melatonin, when used at low to moderate doses (typically up to 5–6 mg daily), is generally safe for most adults and children, with only mild and temporary side effects such as drowsiness, headache, and dizziness being reported. These side effects usually resolve on their own or after stopping the supplement, and serious adverse events are rare or not observed in most studies Givler2023Besag2019Andersen2016+1 MORE.
High-Dose Melatonin Safety
Systematic reviews and meta-analyses examining higher doses of melatonin (≥10 mg) in adults found no significant increase in serious adverse events or withdrawals due to side effects compared to placebo. However, there is a higher risk of mild adverse events like drowsiness, headache, and dizziness at these higher doses. The available evidence suggests a good safety profile, but reporting on adverse events in high-dose studies is often limited, and more robust long-term data are needed Schrire2022Schrire2021.
Long-Term Use and Special Populations
Long-term safety data for melatonin are limited, especially for use beyond six months. Most studies indicate that long-term use in healthy adults does not lead to significant negative effects compared to placebo. However, there is insufficient evidence to make strong recommendations for long-term use in children, pregnant or breastfeeding women, or people with certain medical conditions, as these groups have not been well studied Givler2023Arendt1997Besag2019+2 MORE.
Dosage Considerations in Older Adults
For older adults, studies recommend using the lowest effective dose of immediate-release melatonin to mimic natural circadian rhythms and avoid unnecessarily high blood levels. Higher doses do increase melatonin levels in the body, but there is no clear evidence that higher doses are more effective or safer in this population .
Melatonin in Children and Autism
In children, including those with autism spectrum disorder, melatonin at doses of 1–3 mg has been shown to be safe and well tolerated, with improvements in sleep and minimal side effects. However, as with adults, long-term safety data are still limited Givler2023Malow2011.
Extreme and Special-Use Dosages
Some research has explored very high doses of melatonin (such as 8 mg/kg/day) for severe conditions like COVID-19, suggesting these doses are within safe ranges used in clinical settings for other diseases. However, these recommendations are based on limited clinical experience and animal studies, and should be approached with caution until more human data are available .
Manufacturing and Regulation Concerns
In some countries, melatonin is sold as a dietary supplement and is not strictly regulated, leading to variability in the actual content of melatonin in products. This lack of regulation can affect both the safety and effectiveness of supplementation Givler2023Minich2022.
Conclusion
Melatonin is generally safe at low to moderate doses for short-term use in healthy adults and children, with only mild side effects reported. High-dose and long-term use appear safe based on limited evidence, but more research is needed, especially for vulnerable populations and for use beyond several months. When considering melatonin supplementation, it is best to use the lowest effective dose and consult a healthcare provider, particularly for children, older adults, and those with underlying health conditions.
Sources and full results
Most relevant research papers on this topic